Argos Therapeutics CEO Jeff Abbey has left the company and will start a new role as chief executive of Novadip Biosciences. Argos (OTCMKTS: ARGS) terminated Abbey’s employment on Nov. 30 in connection with the Durham, NC, company’s bankruptcy, according to a securities filing. Also losing their jobs were chief financial officer Richard Katz and chief […]
Original Article: Abbey Exits Bankrupt Argos, Takes CEO Post at Novadip Biosciences